SCLX – scilex holding company (US:NASDAQ)
Stock Stats
News
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis [Yahoo! Finance]
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis
Scilex Holding (NASDAQ: SCLX) had its "hold" rating re-affirmed by analysts at D. Boral Capital.
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
Scilex Holding (NASDAQ: SCLX) had its price target lowered by analysts at D. Boral Capital from $22.00 to $18.00. They now have a "buy" rating on the stock.
Form 8-K Scilex Holding Co For: Apr 11
Form S-8 Scilex Holding Co
Form 10-K Scilex Holding Co For: Dec 31
Form 424B3 Scilex Holding Co
Form 424B3 Scilex Holding Co
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.